Metraipolis › archive › dc_ef8a6898b4bc

Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction — Europe PMC PMID:41977162

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41977162
DOI: 10.3390/ijms27072973
License (as archived): solo-consultazione
Archived: 2026-11-03T22:19:37.907Z
SHA-256 of the archived text: b5da38082d27a82ed299a6cfc9e9e72ef29b8719770ebc72e3e3e147ce972d99
Stable URL of this page: https://metraipolis.com/documento/dc_ef8a6898b4bc

How to cite

Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction — Europe PMC PMID:41977162 — Europe PMC (en), https://europepmc.org/article/MED/41977162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef8a6898b4bc (Metraipolis archive dc_ef8a6898b4bc, sha256 b5da38082d27a82ed299a6cfc9e9e72ef29b8719770ebc72e3e3e147ce972d99)

BibTeX

@misc{dcef8a6898b4bc,
  title = {Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction — Europe PMC PMID:41977162},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41977162},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef8a6898b4bc; sha256 b5da38082d27a82ed299a6cfc9e9e72ef29b8719770ebc72e3e3e147ce972d99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41977162. Agents can read the archived copy with the MCP tool read_document.